CADILLAC Risk Score Calculator
Risk assessment
Select the findings present in a patient with acute myocardial infarction treated with primary PCI.
This score was developed in patients with acute myocardial infarction treated with primary PCI. The original derivation and validation cohorts excluded patients presenting with cardiogenic shock; applicability to other populations may be limited.
About the CADILLAC Risk Score
The CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) Risk Score estimates short- and longer-term mortality risk in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention (PCI).
Seven clinical and angiographic variables are weighted and summed. The original publication defined three strata: low risk (0–2), intermediate risk (3–5), and high risk (≥6).
Score components
| Variable | Criterion | Points |
|---|---|---|
| Age >65 years | Age greater than 65 years. | +2 |
| Baseline LVEF <40% | Baseline left ventricular ejection fraction below 40%. | +4 |
| Renal insufficiency | Creatinine clearance <60 mL/min (as defined in the original model). | +3 |
| Anemia | Original model: hematocrit <39% in men or <36% in women. | +2 |
| Killip class II or III | Killip class II or III at presentation; not class >II. | +3 |
| Final TIMI flow grade 0–2 after PCI | Final epicardial TIMI flow grade below 3. | +2 |
| Three-vessel coronary disease | Angiographic triple-vessel disease. | +2 |
Risk strata
| Total score | Category | 1-year mortality context |
|---|---|---|
| 0–2 | Low | Approximately <1% |
| 3–5 | Intermediate | Approximately 4–5% |
| ≥6 | High | >12% |
Mortality figures above summarize approximate 1-year rates reported in the original publication and are not individualized predictions. The original score is a prognostic model, not a treatment algorithm.
References
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.